We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Super DNA Sequencing Facility Planned

By Biotechdaily staff writers
Posted on 19 Aug 2002
J. More...
Craig Venter has announced plans to create a next-generation high-throughput DNA sequencing facility in Rockville, MD (USA). He will be aided by The Institute for Genomic Research (TIGR), the Institute for Biological Energy Alternatives (IBEA), and The Center for the Advancement of Genomics (TCAG), all of which he founded. All are not-for-profit organizations supported by the J. Craig Venter Science Foundation, which will provide administrative support and coordinate policy and research activities. The new facility will also be not-for-profit and will make information freely available to researchers, not selling it as Celera Genomics did.

As the head of Celera Genomics, Dr. Venter was responsible, along with a US government group, for completing the first sequencing of the human genome. The results have enabled researchers to make many new medical findings and develop new drugs. However, as Dr. Venter points out, even though the cost of sequencing a species has rapidly declined from billions to millions of dollars, there is still a need to substantially reduce these costs even further so more people can benefit from the great promise that genomics holds.

TIGR, TCAG, and IBEA are building a facility to rapidly sequence and analyze genomes in a more cost-effective manner. The new facility will utilize the latest developments in automated DNA sequencing, supercomputing, networking, and high-performance storage technologies. The center will also house a research and development laboratory that will explore advanced technologies from a variety of vendors. Research projects include continuation of ongoing biologic energy research that is seeking new organisms and analyzing known organisms that metabolize carbon or create hydrogen. Another project planned will be to use sequencing to better understand ethno-geographic differences among populations.

"As we continue to explore the implications of individual genetic sequences, this information needs to rapidly become an integral part of medical care and preventive medicine,” said Dr. Venter. "One of our goals in building this facility is to make genomic sequencing of the six billion people on this planet technologically feasible so that everyone can benefit and be empowered by this information.”




Related Links:
TIGR

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.